AU5227999A - Substituted oxazolines as antiproliferative agents - Google Patents
Substituted oxazolines as antiproliferative agentsInfo
- Publication number
- AU5227999A AU5227999A AU52279/99A AU5227999A AU5227999A AU 5227999 A AU5227999 A AU 5227999A AU 52279/99 A AU52279/99 A AU 52279/99A AU 5227999 A AU5227999 A AU 5227999A AU 5227999 A AU5227999 A AU 5227999A
- Authority
- AU
- Australia
- Prior art keywords
- antiproliferative agents
- substituted oxazolines
- oxazolines
- substituted
- antiproliferative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12297398A | 1998-07-27 | 1998-07-27 | |
| US09122973 | 1998-07-27 | ||
| PCT/US1999/016782 WO2000006556A1 (en) | 1998-07-27 | 1999-07-23 | Substituted oxazolines as antiproliferative agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5227999A true AU5227999A (en) | 2000-02-21 |
Family
ID=22405991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU52279/99A Abandoned AU5227999A (en) | 1998-07-27 | 1999-07-23 | Substituted oxazolines as antiproliferative agents |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5227999A (en) |
| WO (1) | WO2000006556A1 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849656B1 (en) | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| ITMI20011758A1 (en) * | 2001-08-09 | 2003-02-10 | Ciba Sc Holding Ag | LIGANDS |
| EP1432706A2 (en) * | 2001-09-26 | 2004-06-30 | Bayer Pharmaceuticals Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| JP2005529923A (en) | 2002-05-13 | 2005-10-06 | イーライ・リリー・アンド・カンパニー | Polycyclic compounds for use as melanin-concentrating hormone antagonists in the treatment of obesity and diabetes |
| CA2602336A1 (en) | 2005-03-31 | 2006-10-05 | Ucb Pharma S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| AR053710A1 (en) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | SPIROHETEROCICLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS |
| MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| BRPI0719210A2 (en) | 2006-10-12 | 2015-05-05 | Xenon Pharmaceuticals Inc | Use of spiro-oxindole compounds as therapeutic agents |
| DK2219451T3 (en) | 2007-11-21 | 2015-01-12 | Oxigene Inc | A method for the treatment of hematopoietic neoplasms |
| EP2350090B1 (en) | 2008-10-17 | 2015-06-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| AR077252A1 (en) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS |
| US8445696B2 (en) | 2009-10-14 | 2013-05-21 | Xenon Pharmaceuticals Inc. | Synthetic methods for spiro-oxindole compounds |
| WO2011075591A1 (en) * | 2009-12-17 | 2011-06-23 | Merial Limited | Anti parasitic dihydroazole compounds and compositions comprising same |
| KR20120131162A (en) | 2010-02-26 | 2012-12-04 | 제논 파마슈티칼스 인크. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
| CA2905509A1 (en) | 2013-03-15 | 2014-09-18 | Memorial Sloan-Kettering Cancer Center | Hsp90-targeted cardiac imaging and therapy |
| US9682033B2 (en) | 2015-02-05 | 2017-06-20 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
| JP2018523712A (en) | 2015-08-18 | 2018-08-23 | マテオン セラピューティクス, インク.Mateon Therapeutics, Inc. | Use of VDAS to improve immunomodulatory therapy against tumors |
| US10918627B2 (en) | 2016-05-11 | 2021-02-16 | Massachusetts Institute Of Technology | Convergent and enantioselective total synthesis of Communesin analogs |
| US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| CN108586443B (en) * | 2018-01-31 | 2019-11-26 | 佳木斯大学附属第一医院 | A kind of drug and preparation method thereof for preventing and treating lung bronchogenic carcinoma |
| WO2020247054A1 (en) | 2019-06-05 | 2020-12-10 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
| CN114656417B (en) * | 2022-04-08 | 2023-10-13 | 合肥工业大学智能制造技术研究院 | Synthesis method and application of chiral oxazoline |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| DE4303840A1 (en) * | 1992-10-22 | 1994-08-11 | Thomae Gmbh Dr K | Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation |
-
1999
- 1999-07-23 AU AU52279/99A patent/AU5227999A/en not_active Abandoned
- 1999-07-23 WO PCT/US1999/016782 patent/WO2000006556A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000006556A1 (en) | 2000-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5227999A (en) | Substituted oxazolines as antiproliferative agents | |
| PL347628A1 (en) | Herbicidal composition | |
| AU8258698A (en) | Isoquinoline-indole compounds as antimicrobial agents | |
| AU4580599A (en) | Stable no-delivering compounds | |
| AU4167699A (en) | Antimicrobial agents | |
| AU3162199A (en) | Copper-containing materials | |
| AU5281299A (en) | Herbicidal agents with substituted phenoxysulfonylureas | |
| AU8441798A (en) | Tricyclically substituted oxazolidinones | |
| AU2616199A (en) | Novel bicyclene-substituted oxazolidinones | |
| AU1424200A (en) | Compounds | |
| AU4501699A (en) | Aminoazole compounds | |
| AU4900699A (en) | Herbicidal composition | |
| AU1434500A (en) | Compounds | |
| AU2656799A (en) | Metal-thiols as imminomodulating agents | |
| AU7432698A (en) | Disinfectant composition | |
| AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
| AU1702000A (en) | Tool arrangement | |
| AU5757799A (en) | Weed-controlling agents | |
| AU3778599A (en) | Herbicidal compositions | |
| AU4511499A (en) | Substituted cyclooctadepsipeptides | |
| AU6124399A (en) | Herbicidal compositions | |
| AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
| AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
| AU6197399A (en) | Substituted herbicidal formylaminotriazines | |
| AU5742599A (en) | Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |